Inventor · disambiguated record
Thomas Brennan
Also filed as: BRENNAN THOMAS · BRENNAN THOMAS J · BRENNAN THOMAS JOSEPH
30 granted patents·29 pending applications·188 citations·filing 1986–2025
96Inventor score
Top patents by PatentIndex Score
59 records- 0187US8431532B2FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using sameBRENNAN THOMAS·Filed 2011·Granted Apr 30, 2013·13 cites·11 claims
- 0286US10273281B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Apr 30, 2019·7 cites·40 claims
- 0386US8445445B2Method of promoting hair growth using FGFR4 extracellular domainsBRENNAN THOMAS·Filed 2010·Granted May 21, 2013·7 cites·22 claims
- 0484US10172937B2Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·5 cites·32 claims
- 0581US8951972B2FGFR1 extracellular domain combination therapies for lung cancerLONG LI·Filed 2011·Granted Feb 10, 2015·2 cites·6 claims
- 0681US8685931B2Hair growth methods using FGFR3 extracellular domainsBRENNAN THOMAS·Filed 2010·Granted Apr 1, 2014·6 cites·41 claims
- 0778US12365719B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·18 claims
- 0878US12334762B2Method and system for battery management including bypassing battery cells in a battery packSOL ARK LLC·Filed 2024·Granted Jun 17, 2025·0 cites·21 claims
- 0975US12465636B2Method of making afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 1075US7788562B2Pattern controlled, full speed ATE compare capability for deterministic and non-deterministic IC dataADVANTEST CORP·Filed 2006·Granted Aug 31, 2010·5 cites·29 claims
- 1173US12034325B1Method and system for battery management including bypassing battery cells in a battery packSOL ARK LLC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 1273US10014820B2Solar panel self-storing adjustable angle mountBRENNAN THOMAS J·Filed 2017·Granted Jul 3, 2018·2 cites·4 claims
- 1373US6929909B2Gene targeting vectors comprising conditional positive selection markersDELTAGEN INC·Filed 2001·Granted Aug 16, 2005·3 cites·27 claims
- 1472US2024266829A1Methods and systems for energy management and optimizationSOL ARK LLC·Filed 2024·Application pending·0 cites
- 1571US11098103B2CD80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·0 cites·8 claims
- 1671US5312016AMastic applicator systemJOHNSTONE PUMP CO·Filed 1992·Granted May 17, 1994·29 cites·14 claims
- 1771US2024266828A1Methods and systems for energy management and optimizationSOL ARK LLC·Filed 2024·Application pending·0 cites
- 1869US9775881B2Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECDFIVE PRIME THERAPEUTICS INC·Filed 2014·Granted Oct 3, 2017·1 cites·19 claims
- 1969US2025269016A1Afucosylated Anti-FGFR2IIIB AntibodiesFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2068US2015203566A1Fgfr1 extracellular domain combination therapiesFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2166US11235059B2Afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·0 cites·59 claims
- 2264US4873461AElectric motor sterilizable surgical power toolSTRYKER CORP·Filed 1988·Granted Oct 10, 1989·69 cites·16 claims
- 2362US11559583B2Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·0 cites·18 claims
- 2461US2018002399A1Fgfr1 extracellular domain combination therapiesFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2560US2022331362A1Methods of b cell expansion for use in cell therapyWALKING FISH THERAPEUTICS·Filed 2022·Application pending·0 cites
- 2659US2015050273A1Afucosylated anti-fgfr2iiib antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2758US6815185B2Methods of creating constructs useful for introducing sequences into embryonic stem cellsFiled 2001·Granted Nov 9, 2004·2 cites·22 claims
- 2858US2019194288A1Cd80 extracellular domain polypeptides and their use in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2956US6942995B2Methods of creating constructs useful for introducing sequences into embryonic stem cellsDELTAGEN INC·Filed 2002·Granted Sep 13, 2005·1 cites·15 claims
- 3056US2025379448A1Power optimization among multiple strings of solar panelsSOL ARK LLC·Filed 2025·Application pending·0 cites
- 3155US11789010B2Methods of treatment with CD80 extracellular domain polypeptidesFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Oct 17, 2023·0 cites·20 claims
- 3254US6060642ASerotonin 5-HT6 receptor knockout mouseUNIV CALIFORNIA·Filed 1998·Granted May 9, 2000·10 cites·3 claims
- 3351US6717032B2Transgenic mice containing DEZ orphan receptor gene disruptionsDELTAGEN INC·Filed 2001·Granted Apr 6, 2004·0 cites·5 claims
- 3451US2007074299A1Transgenic Mice Containing GPCR5-1 Gene DisruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 3551US2018085472A1Combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3650US11014546B2Brake system and method for responding to external boost requests during predetermined loss or degraded boost assist conditionsAUTOLIV ASP INC·Filed 2018·Granted May 25, 2021·0 cites·17 claims
- 3750US2002177134A1Transgenic mice containing PAFR gene disruptionsFiled 2001·Application pending·0 cites
- 3850US2006143722A1OGR1 gene disruptions, compositions and methods relating theretoBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 3950US2014274898A1Hair growth methods using fgfr3 extracellular domainsFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4049US2006075512A1Transgenic mice containing PAFR gene disruptionsBRENNAN THOMAS J·Filed 2005·Application pending·0 cites
- 4147US2003005473A1OGR1 gene disruptions, compositions and methods relating theretoFiled 2002·Application pending·0 cites
- 4247US2002170081A1Transgenic mice containing GPR31 gene disruptionsFiled 2002·Application pending·0 cites
- 4347US2003018989A1Transgenic mice containing GPCR5-1 gene disruptionsFiled 2002·Application pending·0 cites
- 4445US2007107075A1Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses ThereofKLEIN ROBERT D·Filed 2006·Application pending·0 cites
- 4545US2006143724A1Transgenic mice containing anaphylatoxin C3a gene disruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 4645US2002127712A1Transgenic mice containing anaphylatoxin C3a gene disruptionsFiled 2001·Application pending·0 cites
- 4744US2002162131A1Transgenic mice containing cerberus gene disruptionsFiled 2001·Application pending·0 cites
- 4843US2002133840A1Transgenic mice containing disruptions in genes encoding A2D2 calcium ion channel subunit proteinsFiled 2001·Application pending·0 cites
- 4943US2003023998A1Transgenic mice containing 5-HT-2B gene disruptionsFiled 2001·Application pending·0 cites
- 5042US2011319324A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2010·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Brennan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →